MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Cardiovascular Systems Total Liabilities 2011-2026 | CSII
Annual Total Liabilities Cardiovascular Systems
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 73.2 M | 81.6 M | 70.7 M | 70.6 M | 68.9 M | 75.6 M | 41.5 M | 31.9 M | 29.8 M | 30.1 M | 30.9 M | 25.1 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 81.6 M | 25.1 M | 52.5 M |
Quarterly Total Liabilities Cardiovascular Systems
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72.1 M | 69.9 M | 73.2 M | 70.5 M | 66.9 M | 69.1 M | 81.6 M | 81.6 M | 75.1 M | 73.3 M | 70.7 M | 76.9 M | 80.9 M | 75 M | 70.6 M | 70.6 M | 68.6 M | 66.3 M | 68.9 M | 68.9 M | 66.1 M | 70.3 M | 75.6 M | 75.6 M | 46.6 M | 35.4 M | 41.5 M | 41.5 M | 30 M | 31.8 M | 31.9 M | 31.9 M | 32.5 M | 33.9 M | 29.8 M | 29.8 M | 24.9 M | 29.8 M | 30.1 M | 30.1 M | 27.5 M | 31.1 M | 30.9 M | 30.9 M | 30.1 M | 25 M | 25.1 M | 25.1 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 81.6 M | 24.9 M | 52 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M |  USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | USA |
 |
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
82 M | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
52.3 M | $ 3.92 | -1.51 % | $ 136 M | USA |
 |
Alphatec Holdings
ATEC
|
126 M | $ 13.47 | -3.09 % | $ 1.93 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
281 M | $ 7.2 | -6.13 % | $ 517 M |  Israel |
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
Bio-Rad Laboratories
BIO
|
2.79 B | $ 293.69 | -2.09 % | $ 8.29 B | USA |
 |
Bruker Corporation
BRKR
|
3.99 B | $ 42.43 | 2.04 % | $ 6.32 K | USA |
 |
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | USA |
 |
CONMED Corporation
CNMD
|
1.34 B | $ 42.33 | - | $ 1.31 B | USA |
 |
Boston Scientific Corporation
BSX
|
16.7 B | $ 73.47 | - | $ 108 B | USA |
 |
Abbott Laboratories
ABT
|
36.6 B | $ 113.59 | - | $ 198 B | USA |
 |
Cutera
CUTR
|
518 M | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
ClearPoint Neuro
CLPT
|
13.8 M | $ 13.37 | - | $ 361 M | USA |
 |
EDAP TMS S.A.
EDAP
|
45.2 M | $ 4.9 | 6.52 % | $ 183 M |  France |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
10.6 M | $ 25.26 | - | $ 214 M | USA |
 |
InMode Ltd.
INMD
|
81.9 M | $ 14.24 | -2.6 % | $ 1.13 B | Israel |
 |
IRadimed Corporation
IRMD
|
11.5 M | $ 103.08 | -1.97 % | $ 1.31 B | USA |
 |
Second Sight Medical Products
EYES
|
24 M | - | -0.97 % | $ 54.4 M | USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
FONAR Corporation
FONR
|
53.1 M | $ 18.58 | -0.69 % | $ 122 M | USA |
 |
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | USA |
 |
Integer Holdings Corporation
ITGR
|
1.46 B | $ 87.18 | 1.2 % | $ 2.93 B | USA |
 |
Globus Medical
GMED
|
1.07 B | $ 88.26 | -0.52 % | $ 12 B | USA |
 |
Pulmonx Corporation
LUNG
|
77 M | $ 1.45 | - | $ 56.7 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
2.49 B | $ 11.18 | 1.82 % | $ 861 M | USA |
 |
Establishment Labs Holdings
ESTA
|
294 M | $ 72.72 | 0.19 % | $ 2.05 B |  Costa-rica |
 |
Medigus Ltd.
MDGS
|
20 M | - | 10.28 % | $ 55.5 M | Israel |
 |
IRIDEX Corporation
IRIX
|
24.9 M | $ 1.43 | - | $ 23.1 M | USA |
 |
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | USA |
 |
Cytosorbents Corporation
CTSO
|
36.3 M | $ 0.62 | -7.43 % | $ 33.7 M | USA |
 |
Profound Medical Corp.
PROF
|
12.7 M | $ 6.44 | 1.26 % | $ 180 M | Canada |